Regulatory Affairs White Papers (PDF Files)
The MDUFMA User Fee Program in 2005: A Critical Year
Financial Conflict of Interest Series:
- Part I - Financial Conflict
of Interest in Medical Research: Overview and Analysis of Federal and
State Controls
- Part II - Financial
Conflict of Interest in Medical Research: Overview and Analysis of
Institutional Controls
- Part III - Academia, Industry, and the Bayh-Dohl Act: An Implied Duty to Commercialize
Hospital Outpatient Prospective Payment under Medicare: Background, Overview, and Analysis
Medical Technology Reimbursement by the Health Care Financing Administration: Policy Overview
Defining ‘Least Burdensome Means' under the Food and Drug Administration Modernization Act of 1997